Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles

Human Reproduction

Volumn 29, Issue 12, 2014, Pages 2756-2763

  Willis, G R ^a   Connolly, K ^a   Ladell, K ^a   Davies, T S ^b   Guschina, I A ^b   Ramji, D ^b   Miners, K ^a   Price, D A ^a   Clayton, A ^a   James, P E ^a   Rees, D A ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

insulin resistance; microparticles; polycystic ovary syndrome

Indexed keywords

CD11B ANTIGEN; FATTY ACID; FIBRINOGEN RECEPTOR; INSULIN; LIPOCORTIN 5; MICRORNA; PHOSPHATIDYLSERINE; VASCULAR ENDOTHELIAL CADHERIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CELL SIZE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXOSOME; FATTY ACID ANALYSIS; FEMALE; FLOW CYTOMETRY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PLATELET MICROPARTICLE; PROTEIN BLOOD LEVEL; BLOOD; MEMBRANE MICROPARTICLE; METABOLISM; RISK FACTOR; THROMBOCYTE;

ADULT; ANNEXIN A5; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; RISK FACTORS;

EID: 84929646403     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu281     Document Type: Article

References (33)

1. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008; 173: 1210-1219
2. Agouni A, Ducluzeau PH, Benameur T, Faure S, Sladkova M, Duluc L, Leftheriotis G, Pechanova O, Delibegovic M, Martinez MC, et al. Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. PLoS One. 2011; 6: e27809
3. Amabile N, Guérin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am SocNephrol. 2005; 16: 3381-3388
4. Arteaga RB, Chirinos JA, Soriano AO, Wenche J, Horstman L, Jimenez JJ, Mendez A, Ferreira A, de Marchena E, Ahn YS. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol. 2006; 98: 70-74
5. Augustine D, Ayers LV, Lima E, Newton L, Lewandowski AJ, Davis EF, Ferry B, Leeson P. Dynamic release and clearance of circulating microparticles during cardiac stress. Circ Res. 2014; 114: 109-113
6. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001; 104: 2649-2652
7. Carmina E, Longo MCCRA, Rini GB, Lobo RA. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin EndocrinolMetab. 2005; 90: 2545-2549
8. Connolly KD, Willis GR, Datta DBN, Ellins EA, Ladell K, Price DA, Guschina IA, Rees DA, James PE. Lipoprotein-Apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia. J Lipid Res. 2014; doi: 10.1194
9. Ehrmann D, Sturis J, Byrne M, Karrison T, Rosenfield R, Polonsky K. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. J Clin Invest. 1995; 96: 520-527
10. El-Kannishy G, Kamal S, Mousa A, Saleh O, Badrawy AE, Farahaty RE, Shokeir T. Endothelial function in young women with polycystic ovary syndrome (PCOS): implications of body mass index (BMI) and insulin resistance. Obes Res Clin Pract. 2010; 4: e49-e56
11. Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010; 208: 264-269
12. Garaiova I, Guschina I, Plummer S, Tang J, Wang D, Plummer N. A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J. 2007; 6: 4
13. Garbus J, De Luca HF, Loomans ME, Strong FM. The rapid incorporation of phosphate into mitochondrial lipids. J Biol Chem. 1963; 238: 59-63
14. Gündüz Z, DursunI?, Tülpar S, Bastuʇ F, Baykan A, Yikilmaz A, Patiroʇlu T, Poyrazoglu Hakan M, Akin L, Yel S, et al. Increased endothelial microparticles in obese and overweight children. J Pediatr Endocrinol Metab. 2012; 25: 1111-1117
15. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Ryu KW, Bae JM, Kim S. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer. 2003; 39: 184-191
16. Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005; 48: 1622-1630
17. Koiou E, Tziomalos K, Katsikis I, Kalaitzakis E, Kandaraki EA, Tsourdi EA, Delkos D, Papadakis E, Panidis D. Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. Eur J Endocrinol. 2011; 165: 63-68
18. Koiou E, Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Panidis D. Platelet-derived microparticles in overweight/obese women with polycystic ovary syndrome. Gynecol Endocrinol. 2013; 29: 250-253
19. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet J-M, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000; 101: 841-843
20. Martínez-Garciá MA, San-Millán JL, Escobar-Morreale HF. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity. Gene. 2012; 497: 38-44
21. Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012; 97: 3251-3260
22. Nieuwland R, Berckmans RJ, McGregor S, Boïng AN, Th M, Romijn FPH, Westendorp RGJ, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles inmeningococcal sepsis. Blood2000; 95: 930-935
23. Omoto S, Nomura S, Shouzu A, Hayakawa T, Shimizu H, Miyake Y, Yonemoto T, Nishikawa M, Fukuhara S, Inada M. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy. Nephron. 1999; 81: 271-277
24. Orio F, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G, Colao A. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004; 89: 4588-4593
25. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003; 41: 211-217
26. Sang Q, Yao Z, Wang H, Feng R, Wang H, Zhao X, Xing Q, Jin L, He L, WuLet al. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycysticovary syndromein vivo. JClin EndocrinolMetab. 2013; 93: 3068-3079
27. Shah MD, Bergeron AL, Dong JF, López JA. Flowcytometric measurement of microparticles: pitfalls and protocol modifications. Platelets. 2008; 19: 365-372
28. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50-To 100-fold higher specific procoagulant activity than activated platelets. J Thromb Haemost. 2007; 97: 425-434
29. Terrisse AD, Puech N, Allart S, Gourdy P, Xuereb JM, Payrastre B, Sié P. Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost. 2010; 8: 2810-2819
30. Tramontano AF, Lyubarova R, Tsiakos J, Palaia T, DeLeon JR, Ragolia L. Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm. 2010; doi: 10.1155/2010/250476
31. van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012; 64: 676-705
32. Watson S, Blundell HL, Evans WD, Griffiths H, Newcombe RG, Rees DA. Can abdominal bioelectrical impedance refine the determination of visceral fat from waist circumference? Physiol Meas. 2009; 30: N53
33. Webber J, Clayton A. How pure are your vesicles? J Extracell Vesicles. 2013; 2: 19861